11630 SW 97 Street, Miami, Florida 33176, US

Advertising Driven Press Release Distribution

Tag: Device

The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis

Press Release
Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors to rely on the technical and regulatory affairs management expertise of CROs Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”. The report features an extensive study of the current market landscape and future. Read More>>

The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis

Press Release
Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors to rely on the technical and regulatory affairs management expertise of CROs Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”. The report features an extensive study of the current market landscape and future. Read More>>

Artes Electronics company starts selling a device for early diagnosis of skin cancer/melanoma.

Press Release
The device combines Artificial Intelligence(AI) and biophysics. The use of bioimpedance technology will allow you to find dangerous moles on the skin without getting up from the couch. New York - From May 7, Artes Electronics opens sales of a unique device of its kind - a personal mole tracker called NOTA. The device is created to improve the quality of self-diagnosis of moles, which will allow you to find. Read More>>

The medical device batteries market is projected to grow at an annualized rate of 12%, claims Roots Analysis

Press Release
An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices - Market Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others), Rechargeability (Rechargeable and Non-Rechargeable), Application (Hearing Aids, Patient. Read More>>

The medical device label contract manufacturing market is projected to reach USD 509 million in 2030, predicts Roots Analysis

Press Release
Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs, while focusing on the core aspects of product development Roots Analysis has announced the addition of “Medical Device Labels Technology Market, 2019-2030” report to its list of offerings. The report features an extensive study of the current market landscape of companies offering manufacturing services for medical device. Read More>>

The medical device contract manufacturing market is estimated to be worth USD 126 Billion in 2030, predicts Roots Analysis

Press Release
Over the years outsourcing has become a popular trend among medical device developers, allowing such companies to leverage the expertise / substantial production capabilities of CMOs / CDMOs in order to gain cost and time related benefits Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device Contract Manufacturing Market, 2019-2030”. The report features a comprehensive study on the current landscape of contract manufacturing service. Read More>>

Clinical Data from Reprieve Cardiovascular’s Successful First-in-Human Therapy for Acute Heart Failure Presented

Press Release
MILFORD, Mass., -- Reprieve Cardiovascular®, a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF), today announced the results of the first-in-human clinical trial with the company's second generation device, the Personalized Volume Management System (PVM). The study demonstrated that the fully automated fluid management system resulted in safe, effective, efficient and long-lasting decongestion for patients with Acute Heart Failure. The results were presented today. Read More>>

Subscribe to Our Newsletter

For exclusive content regarding the latest trends in the world of Press Release distribution.